 |
|
|
Den 14. november 2012
November 14th 2012 First Grand Hotel, Odense, Denmark
10.00 Words of welcome, Prof Hans Hasselbalch, Chairmen of the Society Incl. date for next meeting, short notes
10.10 CML – update, Prof. Jesper Stentoft and Consultant Ole Weis Bjerrum
10.20 Daliah – study, Dr. Thomas Stauffer Larsen
10.30 Quality of Life – study, Dr. N Brochmann Mortensen
10.40 Vorinostat-study – final results, Dr. Christen Lykkegaard Andersen
10.50 Pathology study Myelofibrosis, Dr. Ann Madelung
Session A. Myelofibrosis – introduction, chairman Consultant Klas Raaschou-Jensen
11.00 Myelofibrosis Danish Guidelines, Prof Hans Hasselbalch
11.25 Allo SCT in Myelofibrosis: The Danish data 1990-2010, Consultant Henrik Sengeløv
11.45 Indications and Timing of Allo SCT in myelofibrosis anno 2012, Prof Joachim Deeg
12.45 Challenging cases in myelofibrosis, Consultant Klas Raaschou-Jensen and colleagues
13.00 Lunch
Session B. MDS - introduction, chairman Consultant Klas Raaschou-Jensen
13.30 MDS Nordic guidelines, Consultant Lars Kjeldsen
13.55 Allo SCT in MDS: The Danish data 1990-2010, Consultant Anders Lindmark
14.15 Coffee
14.30 Indications and Timing of Allo SCT in MDS anno 2012, Prof Joachim Deeg
15.30 Challenging cases in MDS, Consultant Klas Raaschou-Jensen and colleagues
15.45 Closing of the meeting
Please mail cases (both MDS and myelofibrosis) to: Klas: klr@regionsjaelland.dk |
|
|